0.9% Sodium Chloride Injection, USP Facing Active Shortage in Canada
Areazine synthesizes this Health Canada drug-shortage notice directly from Drug Shortages Canada's official public data feed. See our methodology for full source attribution and refresh cadence.
An active shortage of 0.9% Sodium Chloride Injection, USP has been reported by Drug Shortages Canada. Patients are advised to consult with healthcare providers.
What this Health Canada drug-shortage notice tells you, and what most readers miss
This notice was issued by Drug Shortages Canada on April 6, 2026 and geographically references Canada. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, canada, medication, Sodium Chloride.
What's in Shortage
Drug Name: 0.9% SODIUM CHLORIDE INJECTION, USP
Dosage Form: Injection
Current Status: Active
Which Manufacturers Are Affected
The source data for this report does not specify individual manufacturers or their current availability status. The shortage is currently listed as active in the national database.
Why There's a Shortage
No specific reason for this shortage was provided in the source data.
What Patients Should Do
If you or a family member rely on this medication, please consider the following steps:
- Consult your healthcare provider: Speak with your doctor or pharmacist about how this shortage may affect your care.
- Ask about alternatives: Your healthcare team can provide guidance on available therapeutic alternatives or different supply sources.
- Contact the manufacturer: For specific availability updates, you may attempt to contact the drug manufacturer directly.
Disclaimer: Patients should always consult their healthcare provider or a qualified medical professional before making any changes to their medication or treatment plan.
Source
Attribution to Drug Shortages Canada (Report ID: 99361). For more information, visit the official database.
Original source: Drug Shortages Canada Official Notice ↗
Related Drug Shortages
All Drug Shortages →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this Health Canada drug-shortage notice: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,302 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to April 6, 2026.
Frequently Asked Questions
Common questions about this Health Canada drug-shortage notice.